Eli Lilly said on Thursday that India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster ...

The drug, called Mounjaro for diabetes, will be called Zepbound for weight loss, according to a news release from the FDA. Made by Eli Lilly, it’s part of a new class of drugs that includes ...

Eli Lilly & Co is suing compounding pharmacies, wellness centers and medical spas that are selling off-label versions of its Type 2 diabetes drug Mounjaro, which has been popularly used for weight ...

Weight loss drugs Like Mounjaro and Zepbound are now available online with the launch of Eli Lilly's new telehealth platform. LillyDirect offers at-home prescription delivery service of Mounjaro ...

FDA approves weight loss drug Zepbound, joining Ozempic and Wegovy in market 04:47. Eli Lilly has a message for people who are taking prescription medications developed for patients with Type 2 ...

Eli Lilly ramps up its fight against imitation weight-loss drugs. The maker of blockbuster appetite-suppressing drugs Mounjaro and Zepbound is seeking to end a regulatory designation that has ...

Pharmaceutical company Eli Lilly has launched a new telehealth website where patients can be prescribed weight loss drugs. Mounjaro is FDA-approved to treat Type 2 diabetes while Zepbound is FDA ...

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...

For weight loss, Novo Nordisk sells a different dose of the peptide drug under the brand name Wegovy. Lilly designed Mounjaro to pair GLP-1 agonism with the activation of another hormone, GIP.

Investing.com -- Eli Lilly & Co. (NYSE:LLY) plans to start selling its popular weight-loss medication, Mounjaro, in Hong Kong by the end of this year, potentially becoming the first drug of its ...

Indianapolis – Eli Lilly’s diabetes treatment Mounjaro, which is widely used for weight loss, raked in nearly $1 billion in second-quarter sales, or more than $200 million above what Wall ...

INDIANAPOLIS — Eli Lilly’s diabetes treatment Mounjaro, which is widely used for weight loss, raked in nearly $1 billion in second-quarter sales, or more than $200 million above what Wall ...